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ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS (AGEP). CASE REPORT
Walter BELDA JUNIOR & Ana Carolina Junqueira FEROLLA
SUMMARY
Acute Generalized Exanthematous Pustulosis (AGEP) is a drug-induced dermatosis characterized by an acute episode of
sterile pustules over erythematous-edematous skin. It is accompanied by an episode of fever, which regresses a few days after
discontinuation of the drug that caused the condition or as a result of corticosteroid treatment. The main triggering drugs are
antibiotics, mainly beta-lactam ones. Other medications, such as antifungal agents, non steroid anti-inflammatory drugs, analgesics,
antiarrhythmic, anticonvulsant and antidepressant drugs, may also be responsible. Histologically, it is characterized by the existence
of vasculitis, associated with non-follicular subcorneal pustules. A case of a Caucasian female outpatient unit of Dermatology
with AGEP, who presented with generalized pustulosis lesions after the use of cephalosporin for urinary infection is related. The
diagnosis was confirmed by the clinical and pathological correlations, the resolution of the dermatosis after discontinuation of the
drug and use of systemic corticosteroid treatment, and the recurrence of the disorder after the introduction of a similar drug. The
importance of the recognition of this drug-induced dermatosis is given by its main differential clinical and histological diagnoses:
generalized pustular psoriasis and subcorneal pustulosis.
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INTRODUCTION
Acute generalized exanthematous pustulosis (AGEP) is an
uncommon disorder characterized by an acute episode and sudden onset
of erythematous and edematous eruptions of hundreds of sterile pustules.
It is accompanied by fever and is manifested in patients without a previous
history of psoriasis. It has a rapid course and resolves within a few days,
sometimes in response to corticosteroid treatment6,7,17,32. MACMILLAN,
in 1973, was probably the first author to describe a case. He called it
Drug-Induced Generalized Pustular Rash25.
In 1980, in France, BEYLOT et al. introduced the term Acute
Generalized Exanthematous Pustulosis to describe the cases previously
reported by BAKER & RYAN4 in 1968 and set the following criteria
for the diagnosis of AGEP7,17.
• Clinical criterion: acute rash in individuals with no previous history
of psoriasis, occurring after an infection or use of drugs, with
spontaneous cure.
• Histological criterion: existence of vasculitis associated with non-
follicular subcorneal pustulus.
In 1991, ROUJEAU et al., in a retrospective study of 63 cases of
AGEP collected from nine different french health settings, characterized
the illness as having a drug etiology, thus distinguishing it from
pustulous psoriasis28.
The first Brazilian case was described in 1996 by CAMPBELL &
FURTADO, who reported the history of a female patient who developed
AGEP after treatment with ampicillin10.
The etiopathogenesis is still obscure. Viral causes have been
reported, as exemplified by HARO-GABALDON et al. in 1996, who
reported a case of AGEP in a patient with positive serum diagnosis for
cytomegalovirus. The origin has also been traced to pharmaceutical
drugs, related to the treatment of infectious processes. Nevertheless,
data suggest that a viral etiology is responsible for no more than 25%
of the cases. In some studies, serum conversions for enterovirus were
observed, in particular for Coxsackie A9 and Echovirus 11 and 30 and
positive serum diagnoses for hepatitis B and Epstein Barr virus are
also reported17,28. Pharmaceutical drugs are the origin of some 87% of
the cases, among which the most important are antibiotics, especially
beta-lactam and macrolides. The chronological relationship with the
administration of the drug has its own characteristics. The cases due to
antibiotic use usually occur within a short span of time - less than 24
hours - after the administration of the medication. This can be accounted
for by the fact that people have been sensitized by the widespread use
of penicillin. Other prescription drugs may take an average of 18 days
to bring the patient to the clinical picture described28.
Hidroxychloroquine and norfloxacin are described as drugs that can
lead to lesions located on photoexposed areas, and hidroxychloroquine
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has been described as an isolated agent1,2 or one associated with PUVA9.
Mercury (BOLZINGER et al., 1993) and ultraviolet radiation have also
been held responsible for triggering AGEP. In 5% of the cases, the cause
was proven1,2,4,7,8,9,11,12,13,14,15,18,20,21,22,23,24,26,27,28,31,33.
The etiopathogenesis may be explained by the occasional existence
of leukocytoclastic vasculitis, which evokes an Arthus-like
hypersensitivity mechanism30. This could account for the surrounding
immune complexes introduced by the infection or drug.
Nevertheless, ROUJEAU et al. (1991) reported that AGEP is often
present in subjects with a psoriatic history (11 out of 63 cases), but
this fact is argued by other authors28. BAKER & RYAN4 in a study that
comprised 104 cases of pustulous psoriasis, discussed five cases that
they believed had a transitory psoriasiform reaction, occasionally a
toxidermal one. They were not convinced of the psoriatic etiology and
described it as a psoriasiform reaction under the influence of infection
and drugs, without a genetic predisposition. However, they reminded
their readers that corticosteroids, acetylsalicylic acid and promethazine
are all drugs that can induce pustulous psoriasis6,10,28.
In 1980, BEYLOT et al. mentioned that, in some cases, AGEP
may manifest as initial psoriasis, which is disregarded if there is no
recurrence of the psoriasiform lesion within the two years following
the clinical presentation7.
In the present paper, the authors report one case of AGEP caused
by an antibiotic (cephalosporin) and demonstrate the importance of
differential diagnosis.
CLINICAL REPORT
A thirty-one year-old Caucasian female patient, with a urogenital
anomaly since birth, suffered episodes of pyelonephritis and repetitive
intra-abdominal abscesses. She had no previous history of psoriasis.
Forty-eight hours after starting treatment with ceftriaxone,
erythematous lesions appeared on her abdominal area and extend to
the limbs. These lesions were covered by innumerous spread pustules
and accompanied by a febrile peak. The pustulous lesions ruptured,
leaving ulcerative and desquamating areas that recovered the whole
tegument (Fig. 1 and 2).
Laboratory tests showed hypocalcemia (6.5 mg/dL); leukocytosis
with neutrophilia (160%), and increased levels of urea (81 mg/dL) and
creatinine (1.5 mg/dL). Bacterial and fungal cultures of the pustulous
lesions were negatives.
Histopathological exam of a skin biopsy with hematoxylin-eosin
stain showed the presence of subcorneal spongiform pustules,
keratinocyte necrosis, and a perivascular acute inflammatory infiltrate
rich in neutrophils and eosinophils, with focal areas of leukocytoclastic
vasculitis (Fig. 3 and 4). After the diagnosis of AGEP, ceftriaxone was
discontinued and a 60 mg/day of prednisone was introduced, resulting
in remission of lesions on the 7th day of treatment. Prednisone was
gradually discontinued within 15 days because the patient still needed
a broad spectrum antibiotic to treat the urological disease, cefpime
hydrochloride was introduced. There was then a recurrence of the
condition, with disseminated erythematous lesions covered by
innumerous pustules and, this time, associated with purpuric lesions
on the upper and lower limbs from 3rd day of treatment. The suspension
of the antibiotic was followed by resolution of the condition and
disappearance of the lesions, using only topical corticoid and hydration.
In the second episode, the patient presented with improvement of the
clinical picture six days after interruption of drug use. Her laboratory
parameters of urea and creatinine were still slightly altered due to the
urogenital condition, but serum calcium (8.0 mg) and leukocytosis
(10,000) were normal. There was no recurrence of the disorder during
11 months of follow-up.
Fig. 1 - Erythematous lesions with sterile pustules in the abdominal area.
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Fig. 2 - Purpuric lesions and sterile pustules in the hand.
Fig. 3 - Epidermis with spongiform pustule. Mixed inflammatory infiltrate and edema in the upper dermis. (63X HE).
DISCUSSION
Diagnosis of drug-induced cutaneous eruption demands
circumstantial evidence and the exclusion of other diagnostic
possibilities. Although there are clinical and histological similarities
between AGEP and generalized psoriasis, the criteria proposed by
BEYLOT et al. in 1980 enables distinction between the two entities
and differentiation from other pustulous dermal conditions (Snnedon-
Wilkinson Disease; Toxic Epidermal Necrosis; Pustular Miliaria;
Contact pustular dermatitis and Pustular infected disease of the
skin)7,25,28,29. In order to establish the diagnosis between the two entities,
four criteria have been proposed7 :
• history of reaction to the drug
• recent administration of the drug
• duration of pustules
• fever
AGEP is defined by rapid onset following the introduction of the
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drug (less than 24 hours) and marked predominance of antibiotics as
triggering agents (80% of the cases). Clinically, it is characterized by
polymorphism of eruption, single episode, quick course of action,
absence of arthritis and frequent administration of drugs3,10,28. However,
in pustulous psoriasis, the eruption is monomorphic, last longer and
recurs. Arthritis is associated in 32% of the cases, and drugs are rarely
implicated in the etiology. The involution of the condition is slower,
taken between 10 and 14 days (Table I)3.
Clinically, lesions begin on the face and, within a few hours, they
spread to the trunk and limbs, or begin to arise in intertriginous areas.
After that there is annular desquamation for a few days, possibly
accompanied by polymorphic lesions, especially purpuric lesions on
Table 1
Comparison of clinical, laboratory and histopathology aspects
of AGEP and GPP
Characteristics AGEP GPP
Age Adults Adults
Cause Drugs; viral infection Respiratory tract
infection
Clinical Numerous confluent, Confluent pustules
characteristics generalized, diffuse on erythematous
on erythematous skin skin
Fever High Prolonged
Leukocytosis Yes Yes
Course Self-limited Recurrent
Histology Spongy, subcorneal Spongy, subcorneal
pustules, leukocytoclastic pustules, psoriasiform
vasculitis, eosinophils acanthosis
AGEP = Acute Generalized Exanthematous Pustulosis; GPP = Generalized
Pustular Psoriasis.
Fig. 4 - Spongiform pustule bottom in the epidermis and edema and neutrophils in papillary dermis. (160X HE).
the legs and feet. The mucous membranes are affected in 25% of the
cases. Sometimes the pustules converge, giving the false aspect of positive
Nikolsky’s sign, and leading to misinterpretation of toxic epidermal
necrosis or staphylococcal scalded skin syndrome (SSSS)6,7,10,17,32.
In the present case, the clinical condition started with erythematous
lesions on the abdominal region, unlike what has been described in the
literature, with an onset of pustules that spread over 24-hour period of
time. The clinical picture included fever, and there were no mucous
lesions or arthritis, thus coinciding with the description of AGEP in
the international literature. There was regression of the condition after
discontinuation of medication and introduction of corticosteroid
treatment. Nevertheless, we observed a clinical recurrence manifested
by polymorphic lesions in the form of purpuric lesions on upper and
lower limbs after the introduction of a similar drug, cefpime
hydrochloride.
Reactions of hypersensitivity to cephalosporins are among the most
common drug adverse effects, and there is no evidence that one
cephalosporin has a higher or lower likelihood of causing sensitization.
The observed reactions seem to be identical to those caused by
penicillin; this could be related to the beta-lactam structure shared by
two groups. Both generations of cephalosporins have the same beta-
lactam structure. Owing to the similar structures of penicillin and
cephalosporin, patients allergic to one of these drug classes may
manifest cross-reactivity when taking a drug from the other class. There
are no skin patch tests capable of safely predicting whether a patient is
allergic or not to the various groups of cephalosporins16. In lab tests
we may observe leukocytosis with neutrophilia and eosinophilia.
Hypocalcemia may also be found, mainly in the cases accompanied
by hypoalbuminemia. Transitory renal failure may occur. In some cases
there is a momentary increase in aminotransferasis. The culture of
pustules is negative28,32. In the present case, leukocytosis with
neutrophilia, hypocalcemia and sterile culture of pustules were
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observed. The histopathological condition presented in this case was
compatible with the diagnosis of AGEP, including the presence of
spongy pustules and necrosis of keratinocytes. The occurrence of
eosinophil-rich subcorneal or intraepidermal pustules, the perivascular
infiltrate with eosinophils and leukocytoclastic vasculitis with fibrinoid
deposit is consistent with AGEP. Histologically, the differential
diagnosis from pustulous psoriasis is made by the presence in the latter
of hyperplasia of the epidermis and papilloacanthosis3,28. In the present
case, clinical and histological characteristics, chronological relation
with administration of cephalosporin and, above all, the quick resolution
of the condition following the interruption of medication, met the
criteria for diagnosis of AGEP.
CONCLUSION
The authors reported a case of AGP following the administration
of cephalosporin, concluded that differential diagnosis among pustulous
affections is important and essential before introduce the treatment to
the patient.
RESUMO
Pustulose exantemática aguda generalizada (AGEP)
A pustulose exantemática aguda generalizada (AGEP) é uma
dermatose induzida por droga, caracterizada por episódio agudo de
aparecimento de pústulas estéreis sobre base eritemato-edematosa,
acompanhado de febre. Este quadro regride espontâneamente após a
suspensão da droga ou em resultado do tratamento com corticóide
sistêmico. As principais drogas envolvidas são agentes antifúngicos,
antiinflamatórios não hormonais, analgésicos, antiarrítmicos e
anticonvulsivantes. Histologicamente caracteriza-se por vasculite
associada a pústulas subcórneas não foliculares. Relatamos caso de
paciente branca, feminina, que se apresentou com lesões pustulosas
generalizadas após o uso de cefalosporina. O diagnóstico foi confirmado
pelos achados clínicos e histológicos; pela resolução do quadro após a
suspensão da droga e pela introdução de corticóide sistêmico, e pela
recorrência após a introdução de droga similar. A importância do
reconhecimento deste tipo de dermatose induzida por droga reside na
necessidade importante de seu diagnóstico diferencial, clínico e
histológico, com a psoríase pustulosa generalizada e a pustulose
subcórnea, particularmente no que tange às opções terapêuticas que se
apresentam para o tratamento das mesmas.
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